DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
DRG and its group companies would like to inform you that we have updated our website privacy policy.
New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here
ePharma Consumer®
Research and expertise to help pharma brands build stronger relationships with patients
Decision Resources Group's ePharma Consumer® research, insights and advisory services help pharma brands:
Understand how patients want to interact with pharma companies
Plan multichannel and content strategy and tactics by disease state
Determine which digital investments will drive results
Our analysts provide brands answers to questions such as:
Digital channel strategy: What are the key online channels for pharma content distribution across the patient journey? What type of information and resources do consumers want across digital channels from pharma? How does digital channel usage impact health-related actions?
The prescription journey, from pre-Rx to medication adherence: What channels are most impactful in driving specific drug requests? Where do patients go after receiving a prescription from their doctor? What types of information do they research and how does this impact decisions to fill a prescription? What are the causes of non-adherence and how can pharma support medication compliance?
Value-added services and patient support: At what point along the patient journey is the need for pharma patient support strongest? What type of patient support services is most in demand, and what are the best distribution channels for these resources?
Promotional tactics: What types of prescription drug ads are consumers most receptive to? Which are most relevant to consumers? How impactful are digital advertising campaigns in activating consumers, versus DTC TV?
Disease states (US):
Patient, Caregiver & Rx taker segments
Acid Reflux
Acne
ADD/ADHD
Age-related Macular Degeneration
Allergies
Angina
Arthritis
Osteoarthritis
Rheumatoid arthritis (mild, moderate-severe)
Psoriatic arthritis
Parent to child with child ankylosing spondylitis
Parent to child with juvenile idiopathic arthritis
Parent to child with plaque psoriasis
Parent to child with Crohn's Disease
Arrhythmia
Asthma (mild, moderate-severe)
Atrial Fibrillation
Autism
Atopic dermatitis
Bipolar Disorder
Cancer (diagnosed past 3 years)
Breast Cancer
Prostate Cancer
Skin Cancer
Chronic Pain
Chronic Bronchitis
Chronic kidney disease
COPD
Crohn's Disease
Cystic Fibrosis
Deep Vein Thrombosis
Depression
Diabetes (T1 & T2)
Eczema (mild, moderate-severe)
Emphysema
Epilepsy
Erectile Dysfunction
Fibromyalgia
Generalized Anxiety Disorder
Glaucoma
Gout
Growth Hormone Deficiency
Heart Attack past 3 years (ages 45+)
Heart failure
Heart Disease
Hepatitis C
High Cholesterol
HIV or AIDS
Insomnia or Sleep Disorder
Irritable Bowel Syndrome
Low testosterone
Migraine
Multiple Sclerosis
Osteoporosis
Organ transplant recipient
Overactive Bladder or Urinary Incontinence
Overweight or obese (Weight management or obesity for info seekers)
Psoriasis (mild, moderate-severe)
Stroke
Learn more about our multichannel stakeholder engagement solutions